Weekly FDA Drug Pipeline Calendar (Nov 28 - Dec 2)
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Top Medical News of the Week
$Imago BioSciences(IMGO.US$ traded higher after it was announced that it will be acquired by $Merck & Co(MRK.US$ for $36 per share in cash. The deal totals an estimated $1.35 billion.
$Palisade Bio(PALI.US$ announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return bowel function following surgery.
$Palisade Bio(PALI.US$ announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return bowel function following surgery.
EVENTS TO WATCH
Clinical Trials on Alzheimer's Disease Conference - $Biogen(BIIB.US$ $BioVie(BIVI.US$ $ROCHE HOLDING AG(RHHBY.US$ $Anavex Life Sciences(AVXL.US$ Nov 29 - Dec 1
Nov Consumer Confidence 10 AM ET
Nov Consumer Confidence 10 AM ET
Wednesday, November 30
PDUFA PR $Scynexis(SCYX.US$ BREXAFEMME (ibrexafungerp) - (CANDLE)
PDUFA PR $Y-mAbs Therapeutics(YMAB.US$ Omburtamab
PDUFA PR $Y-mAbs Therapeutics(YMAB.US$ Omburtamab
Source: CNBC, BioPharmCatalyst, Benzinga
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
We are the content provider of Moomoo Courses.
909Followers
8Following
1458Visitors
Follow
71156064 : I'll get excited when NWBO comes up for review.
BioPharm Insight USOP 71156064: it's so volatile, trade safe.